Freedom Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$438K Sell
2025
Q1
$323K Sell
2024
Q4
$394K Buy
2024
Q3
$383K Sell
2024
Q2
$464K Buy
2024
Q1
$447K Sell
2023
Q4
$529K Buy
2023
Q3
$380K Sell
2023
Q2
$509K Buy
2023
Q1
$391K Sell
2022
Q4
$354K Sell
2022
Q3
$1.73M Buy
2022
Q2
$778K Sell
2022
Q1
$1.13M Sell
2021
Q4
$1.84M Buy
2021
Q3
$2.68M Buy
2021
Q2
$3.46M Sell
2021
Q1
$2.8M Buy